Skip to main content

Advertisement

ADVERTISEMENT

Medical Services

News
10/20/2021
Tom Valentino, Senior Editor
Adamis Pharmaceuticals Corp. announced on Monday that FDA has approved its high-dose (5 mg/0.5 mL) naloxone injection product to treat opioid overdose.
Adamis Pharmaceuticals Corp. announced on Monday that FDA has approved its high-dose (5 mg/0.5 mL) naloxone injection product to treat opioid overdose.
Adamis Pharmaceuticals Corp....
10/20/2021
Addiction Professional
News
10/05/2021
Tom Valentino, Senior Editor
Emergency department visits and hospitalizations by patients with alcohol and substance use disorders are on the rise, showing a need for health systems to develop hospital-based interventions, according to researchers from the University of...
Emergency department visits and hospitalizations by patients with alcohol and substance use disorders are on the rise, showing a need for health systems to develop hospital-based interventions, according to researchers from the University of...
Emergency department visits and...
10/05/2021
Addiction Professional
News
09/20/2021
Tom Valentino, Senior Editor
In a study recently published by Oregon Health and Science University, about 8% of patients hospitalized with opioid use disorder died with a year of discharge, a rate similar to the 1-year death rate for those who have suffered a heart...
In a study recently published by Oregon Health and Science University, about 8% of patients hospitalized with opioid use disorder died with a year of discharge, a rate similar to the 1-year death rate for those who have suffered a heart...
In a study recently published by...
09/20/2021
Addiction Professional
07/28/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
The University of Illinois Chicago College of Nursing has launched a training program for new nurse practitioner graduates to work with opioid use disorder patients. The program is being funded with a $1.8 million grant from the Health...
The University of Illinois Chicago College of Nursing has launched a training program for new nurse practitioner graduates to work with opioid use disorder patients. The program is being funded with a $1.8 million grant from the Health...
The University of Illinois...
07/28/2021
Addiction Professional
News
07/21/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
A group of community coalitions, anti-drug organization MATFORCE and Arizona HIDTA have developed a counterfeit pill and fentanyl toolkit to help educate communities and prevent and reverse overdoses.
A group of community coalitions, anti-drug organization MATFORCE and Arizona HIDTA have developed a counterfeit pill and fentanyl toolkit to help educate communities and prevent and reverse overdoses.
A group of community coalitions,...
07/21/2021
Addiction Professional
News
07/20/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
When administered by emergency department caregivers, high-dose buprenorphine therapy is safe and well tolerated in individuals with opioid use disorder who are experiencing withdrawal symptoms, according to results of a study supported by...
When administered by emergency department caregivers, high-dose buprenorphine therapy is safe and well tolerated in individuals with opioid use disorder who are experiencing withdrawal symptoms, according to results of a study supported by...
When administered by emergency...
07/20/2021
Addiction Professional
05/17/2021
Opioid tablets prescribed to patients after same-day surgical procedures in orthopedics and general surgeries dropped 50% from January 2017 to December 2020, but still exceed best practice recommendations from experts in the field, according...
Opioid tablets prescribed to patients after same-day surgical procedures in orthopedics and general surgeries dropped 50% from January 2017 to December 2020, but still exceed best practice recommendations from experts in the field, according...
Opioid tablets prescribed to...
05/17/2021
Addiction Professional
05/11/2021
The U.S. Food and Drug Administration has approved a higher dose naloxone nasal spray product. The new product, Kloxxado, delivers 8 mg of naloxone into the nasal cavity, which is double the 4 mg delivered in Narcan. A 2 mg formulation of...
The U.S. Food and Drug Administration has approved a higher dose naloxone nasal spray product. The new product, Kloxxado, delivers 8 mg of naloxone into the nasal cavity, which is double the 4 mg delivered in Narcan. A 2 mg formulation of...
The U.S. Food and Drug...
05/11/2021
Addiction Professional
04/27/2021
The Ohio Department of Mental Health and Addiction Services is providing access to Pear Therapeutics’ prescription digital therapeutics reSET and reSET-O for the treatment of substance use disorder and opioid use disorder, respectively. The...
The Ohio Department of Mental Health and Addiction Services is providing access to Pear Therapeutics’ prescription digital therapeutics reSET and reSET-O for the treatment of substance use disorder and opioid use disorder, respectively. The...
The Ohio Department of Mental...
04/27/2021
Addiction Professional
Rx Summit Spotlight | Developing Structure Around Post-Overdose Outreach Programs
03/17/2021
As rates of substance use disorders rise across the U.S., post-overdose outreach programs have become an increasingly popular tool for engaging at-risk individuals. But as a relatively new concept, practices for documentation and measurement...
As rates of substance use disorders rise across the U.S., post-overdose outreach programs have become an increasingly popular tool for engaging at-risk individuals. But as a relatively new concept, practices for documentation and measurement...
As rates of substance use...
03/17/2021
Addiction Professional

Advertisement

Advertisement